Poland at a glance
- Population
- 36.4 million 2025
- Life expectancy at birth
- 78.4 years, 2024
- People aged 65 and over
- 20.8 % of people, 2025
- Health spending per person
- 2,014 US$ per person, 2024
- Doctors
- 4.03 per 1,000 people, 2023
Updated
Reviewed by Vidhi Upadhyay
Poland Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$246.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $192.9 Mn | — | — |
| 2025 (base) | $210.3 Mn | +$17.4 Mn | — |
| 2026 (forecast) | $229.2 Mn | +$18.9 Mn | +9% |
| 2027 (forecast) | $249.8 Mn | +$20.6 Mn | +18.8% |
| 2028 (forecast) | $272.3 Mn | +$22.5 Mn | +29.5% |
| 2029 (forecast) | $296.8 Mn | +$24.5 Mn | +41.2% |
| 2030 (forecast) | $323.6 Mn | +$26.7 Mn | +53.9% |
| 2031 (forecast) | $352.7 Mn | +$29.1 Mn | +67.7% |
| 2032 (forecast) | $384.4 Mn | +$31.7 Mn | +82.8% |
| 2033 (forecast) | $419.0 Mn | +$34.6 Mn | +99.3% |
| 2034 (forecast) | $456.7 Mn | +$37.7 Mn | +117.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $210.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $456.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Technology, application and end user (see all) |
| Key players | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all) |
| Regulator in Poland | URPLSource: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.
Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.
The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need CE marking under the EU Medical Device Regulation (MDR); in Poland, the Office for Registration (URPL) oversees them.[1] The National Health Fund (NFZ) pays for public care for insured people, and the Ministry of Health decides which medicines are reimbursed.[2]
[1] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.
[2] National Health Fund (NFZ). Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Poland.
What doctors and scientists are doing in Molecular Diagnostics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
Poland · 3 shared keywords
Poland · 1 shared keyword
Poland · 1 shared keyword
Poland · 1 shared keyword
Poland · 1 shared keyword
Poland
Pharmaceuticals · Global
Digital Health · Global
Healthcare Services · Global
Healthcare Services · Global
Digital Health · Global
Healthcare Services · Global